Name: Name:(R)-Boroleucine-(1S,2S,3R,5S)-(+)-pinanediol ester trifluoroacetate
Brand: AABLOCKS
SKU: AA0026UM
Rating: 90 (10 reviews)

Technical Information

Catalog Number: AA0026UM

Chemical Name: (R)-Boroleucine-(1S,2S,3R,5S)-(+)-pinanediol ester trifluoroacetate

CAS Number: 179324-87-9

Molecular Formula: C17H29BF3NO4

Molecular Weight: 379.2227

MDL Number: MFCD10566030

SMILES: OC(=O)C(F)(F)F.CC(C[C@@H](B1O[C@H]2[C@](O1)(C)[C@H]1C[C@@H](C2)C1(C)C)N)C

Properties

Form: Solid

MP: 157-159°C

Storage: Inert atmosphere;2-8℃;

Complexity: 457

Covalently-Bonded Unit Count: 2

Defined Atom Stereocenter Count: 5

Heavy Atom Count: 26

Hydrogen Bond Acceptor Count: 8

Hydrogen Bond Donor Count: 2

Rotatable Bond Count: 3

Downstream Synthesis Route

4530-20-5

179324-87-9

847494-18-2

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2009/20448,2009,A1Locationinpatent:Page/Pagecolumn25

[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-JP2016/14038,2016,ALocationinpatent:Paragraph0085

[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-KR2016/40735,2016,ALocationinpatent:Paragraph0117-0119

[4]CurrentPatentAssignee:MilleniumPharmaceuticalsInc.;Olhava,EdwardJ.;Danca,MihealaD.-2016Locationinpatent:Paragraph0117;0118;0119;0120

[5]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-JP2016/172768,2016,ALocationinpatent:Paragraph0084

[6]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-JP2018/24694,2018,ALocationinpatent:Paragraph0084;0085

[7]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US7442830,2008,B1Locationinpatent:Page/Pagecolumn21-23

[8]CurrentPatentAssignee:MilleniumPharmaceuticalsInc.;Olhava,EdwardJ.;Danca,MihealaD.-2016Locationinpatent:Paragraph0117;0118;0119;0120

[9]Lei,Meng;Feng,Huayun;Bai,Enhe;Zhou,Hui;Wang,Jia;Shi,Jingmiao;Wang,Xueyuan;Hu,Shihe;Liu,Zhaogang;Zhu,Yongqiang[BioorganicandMedicinalChemistry,2018,vol.26,#14,p.3975-3981]

[10]Lei,Meng;Feng,Huayun;Bai,Enhe;Zhou,Hui;Wang,Jia;Qin,Yanru;Zhang,Haoyang;Wang,Xueyuan;Liu,Zhaogang;Hai,Ou;Liu,Jia;Zhu,Yongqiang[OrganicandBiomolecularChemistry,2019,vol.17,#3,p.683-691]

76-05-1

514820-48-5

179324-87-9

[1]Locationinpatent:experimentalpartIvanov,AndreyS.;Zhalnina,AnnaA.;Shishkov,SergeyV.[Tetrahedron,2009,vol.65,#34,p.7105-7108]

[2]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.;BUCKSTERESAANNE-WO2009/4350,2009,A1Locationinpatent:Page/Pagecolumn11;12

[3]CurrentPatentAssignee:SHENZHENTARGETRXINC-EP3476850,2019,A1Locationinpatent:Paragraph0038;0044

[4]CurrentPatentAssignee:DRREDDY'SLABORATORIESLIMITED-WO2009/36281,2009,A2Locationinpatent:Page/Pagecolumn36

[5]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-US2013/85277,2013,A1Locationinpatent:Paragraph0044

[6]Tan,Joanne;Grouleff,JulieJ.;Jitkova,Yulia;Diaz,DiegoB.;Griffith,ElizabethC.;Shao,Wenjie;Bogdanchikova,AnastasiaF.;Poda,Gennady;Schimmer,AaronD.;Lee,RichardE.;Yudin,AndreiK.[JournalofMedicinalChemistry,2019,vol.62,#13,p.6377-6390]

(aR,3aS,4S,6S,7aR)-hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine2,2,2-trifluoroacetate

667403-46-5

1201903-02-7

[1]Patent:WO2016/155684,2016,A1.Locationinpatent:Page/Pagecolumn2;3;9

[2]Patent:CN106916177,2017,A.Locationinpatent:Paragraph0156;0162;0163;0164

[3]Patent:WO2009/154737,2009,A1.Locationinpatent:Page/Pagecolumn62

[4]Patent:WO2018/173071,2018,A1.Locationinpatent:Page/Pagecolumn16;17

179324-87-9

1918989-80-6

CASUnavailable

[1]Lei,Meng;Feng,Huayun;Wang,Cheng;Li,Hailing;Shi,Jingmiao;Wang,Jia;Liu,Zhaogang;Chen,Shanshan;Hu,Shihe;Zhu,Yongqiang[BioorganicandMedicinalChemistry,2016,vol.24,#11,p.2576-2588]

[2]CurrentPatentAssignee:NANJINGFORESTRYUNIVERSITY-CN105732683,2016,ALocationinpatent:Paragraph0173;0174;0175

(aR,3aS,4S,6S,7aR)-hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine2,2,2-trifluoroacetate

667403-46-5

7732-18-5

77-92-9

2,2’-{2-(1R)-1-((2,5-dichlorobenzoyl)aminoacetyl}amino)-3-methylbutyl-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diaceticacid

[1]Patent:WO2019/43544,2019,A1.Locationinpatent:Page/Pagecolumn4;5

179324-87-9 | (R)-Boroleucine-(1S,2S,3R,5S)-(+)-pinanediol ester trifluoroacetate